Patient Centricity
Patient Centricity
Recherche
Boehringer Ingelheim and Nxera Pharma (formerly Sosei Heptares), operating from Basel, Switzerland, collaborate to develop first-in-class treatments targeting all symptoms of schizophrenia
Boehringer Ingelheim and Nxera Pharma Co., Ltd. , have entered a global collaboration.
Reconnaître et comprendre le diabète de type 2
Quels sont les symptômes classiques du diabète de type 2 ?